Mirago 50 Tablet ER
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Mirabegron (50mg)
Overview Mirago 50 Tablet ER
Mirago 50 Extended-Release tablets alleviate overactive bladder symptoms such as urinary frequency, urgency, and incontinence. This medication relaxes bladder muscles, improving urine storage capacity. Always adhere to your physician's prescribed dosage and duration. It may be taken with or without food; swallow the tablet whole, avoiding crushing or chewing. Discontinuing treatment prematurely may exacerbate symptoms; complete the prescribed course for optimal results. Potential side effects include constipation, headache, hypertension, nasal congestion, urinary tract infections, tachycardia, and arthralgia. Report any persistent or bothersome side effects to your doctor immediately. Before starting treatment, disclose all current medications and any pre-existing health conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment require careful monitoring and regular check-ups as directed by their doctor.
Primary Ingredients of Mirago 50 Tablet ER
No text provided. Please provide the text you wish me to rephrase.
Uses of Mirago 50 Tablet ER
Managing symptoms associated with overactive bladder
Major Benefits of Mirago 50 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Mirago 50 ER tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, however, consistent timing is recommended.
Common Side effects of Mirago 50 Tablet ER:
- Constipation
- Headache
- High blood pressure
- Nasal inflammation
- Urinary tract infection
- Fast heart rate
- Joint pain
How to use Mirago 50 Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Mirago 50 ER tablets can be consumed with or without food, though consistent timing is recommended.
How Mirago 50 Tablet ER works:
Mirago 50 Extended-Release Tablets contain a beta-3 adrenergic agonist. Its mechanism of action involves stimulating bladder beta-3 receptors, leading to detrusor muscle relaxation and a reduction in urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
It's recommended to avoid alcohol while taking Mirago 50 Tablet ER. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Extended-release Mirago 50mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Mirago 50mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Mirago 50 ER tablets.
KidneyCAUTION
For patients with severe kidney impairment, Mirago 50 Extended-Release tablets require careful administration. Dosage modification of Mirago 50 Extended-Release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Mirago 50 ER tablets cautiously, potentially requiring dosage modification. Consult your physician. Mirago 50 ER tablets are contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Mirago 50 Tablet ER :
For Mirago 50 Tablet ER, take a missed dose promptly if you remember. However, if your next dose is nearly due, omit the missed one and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Mirago 50 Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Anilide-based compound |
| Developing Habits | No. |
| Treatment Category | Urology |
| Action class | Beta-3 agonist for bladder control |



